AG
RXDX

Artal Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Artal Group’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-121,756
Closed -$13.1M – 135
2023
Q1 		$13.1M Buy
+121,756
New +$13.1M 0.78% 31